Asbestos &amp; Mesothelioma News

Sticky

Asbestos Trust Money is Already Waiting

For decades, the carcinogenic qualities of asbestos have affected hard working individuals who worked in industrial, chemical, electrical, and other trade settings. Airborne asbestos fibers are easily inhaled and can lead to many asbestos-related illnesses such as lung cancer, asbestosis, and mesothelioma. The long latency period between asbestos exposure and illness not only results in difficult treatments, but also means you or a loved one may be entitled to compensation years after initial exposure. Bankruptcy Trust Once the dangers of asbestos became known companies were forced to admit their awareness and responsibility. This resulted in many filing for Chapter 11 bankruptcy protection...

29 May

Sticky

Asbestos Exposure Linked To Doll Manufacturers

The first uses of asbestos date back thousands of years, but it wasn’t until the 20th century that its use became rampant not only because of its versatility, but also because of the mineral’s unique characteristics; it’s durable, heat resistant, and abundant. Occupational exposure to this carcinogen is one of the main contributing factors in those who are suffering from asbestos-related illnesses such as lung cancer, mesothelioma, and asbestosis. Steelworkers, chemical plant workers, tradesmen, and even those who worked in shipyards were most likely exposed to asbestos due to the nature of their work, but as time has gone on,...

29 May

Sticky

Nintedanib and Pembrolizumab – Hope for Mesothelioma Patients

The latest findings in cancer treatments for the often fatal mesothelioma have scientists and researchers hopeful that they are one step closer in finding a consistent, effective treatment for the asbestos-caused cancer. The LUME-Meso Phase II trial for patients with malignant pleural mesothelioma focused on the administration of the triple angiokinase inhibitor called Nintedanib. This oral treatment is designed to block cancer growth by hindering protein kinases in cancer cells and stop cancer cell from growing their own blood vessels. The latest completed clinical trial (Phase II) showed progression-free survival goal was met. Progression-free survival is the amount of time after treatment that...

29 May

Sticky

National Asbestos Awareness Week: April 1 – April 7, 2017